¹Department of Pharmacology (Clinical Pharmacology), Sri Aurobindo Medical College &PG Institute, Sri Aurobindo University, Indore, Madhya Pradesh, India

²Chairman SEAC, Government of Madhya Pradesh Bhopal Madhya Pradesh, India

*Corresponding author: Ashok Kumar, Department of Pharmacology, Sri Aurobindo Medical College &PG Institute, Sri Aurobindo University, Indore, Madhya Pradesh, India-453555, Email: [email protected]

Received Date: May 11, 2024

Published Date: June 08, 2024

Citation: Kumar A, et al. (2024). Hyperglycemia and Its Association with Cardio Vascular Disease (Cvd) Post COVID-19 Era. Mathews J Case Rep. 9(5):167

Copyrights: Kumar A, et al. © (2024).

ABSTRACT

This commentary presents a comprehensive framework for understanding and addressing the complex interplay between hyperglycemia and cardiovascular disease (CVD) in the aftermath of the COVID-19 pandemic. We delve into the emerging evidence highlighting the heightened cardiovascular risk posed by hyperglycemia in the post-COVID-19 era and explore the underlying mechanisms driving this association. Building upon this foundation, we propose practical strategies for healthcare providers to effectively manage hyperglycemia and mitigate its impact on cardiovascular health. By emphasizing the importance of early detection, personalized intervention, and multidisciplinary collaboration, we aim to equip clinicians with the tools necessary to navigate the evolving landscape of hyperglycemia-related CVD in the post-COVID-19 era.

Keywords: Cardiovascular Disease (CVD), Post-COVID-19 Era Association, Management Risk Mechanisms, Prevention Intervention, Healthcare Strategies.